ELAN vs NDAQ · rev $2.74B vs P/E 41, rev $2.53B
Elanco Animal Health (ELAN) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
ELAN currently screens at market cap $11.80B. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the ELAN and NDAQ stock pages for the full models.
Not investment advice.